FindTrial
Sign In

Trial to compare post-operative analgesia of ropivacaine versus dexmedetomidine and ropivacaine in pectoral nerve block for breast cancer surgery.

A randomized double blind prospective interventional study to compare post-operative analgesia of ropivacaine versus dexmedetomidine as an adjuvant to ropivacaine in pectoral nerve block for breast cancer surgery at SMS HOSPITAL JAIPUR during 2018-2019.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/08/020815
Enrollment
60
Registered
2019-08-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: C509- Malignant neoplasm of breast of unspecified site Health Condition 3: C509- Malignant neoplasm of breast of unspecified site

Interventions

Intervention1: ROPIVACAINE: 0.25% ROPIVACAINE 10ML IN PEC1 AND 20ML IN PEC2 BLOCK just after induction of patient. Control Intervention1: ROPIVACAINE AND DEXMEDETOMIDINE: O.25% ROPIVACAINE 10 ML IN PE

Sponsors

SMS MEDICAL COLLEGE JAIPUR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: PATIENT UNDERGOING BREAST SURGERY. ASA GRADE 1 AND 2.

Exclusion criteria

Exclusion criteria: PATIENT REFUSAL. DERANGED COAGULATION PROFILE. INFECTION AT INJECTION SITE. HISTORY OF OPIOID USE OR ADDICTION. OBESITY WITH BMI >35 KG/METER SQUARE. PREGNANCY.

Design outcomes

Primary

MeasureTime frame
FIRST RESCUE ANALGESIA.Timepoint: 24HOURS—

Secondary

MeasureTime frame
TOTAL POST OPERATIVE ANALGESIC CONSUMPTION. SIDE EFFECTS IF ANY.Timepoint: 24HOURS—

Countries

India

Contacts

Public ContactSUSHIL BHATI

SMS MEDICAL COLLEGE,JAIPUR

drsushilbhati@gmail.com9414779786

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026